Predict your next investment

Corporation
HEALTHCARE | Biotechnology
insight.co.il

See what CB Insights has to offer

Founded Year

1991

Stage

Asset Sale - II | AssetsPurchased

About InSight Biopharmaceuticals

InSight Biopharmaceuticals specializes in the development, manufacturing, and commercialization of biosimilars and biopharmaceuticals.

InSight Biopharmaceuticals Headquarter Location

12 Hamada Street Beit Tamar Building Entrance 8

Rehovot,

Israel

+972 89463032

Latest InSight Biopharmaceuticals News

Struggling InSight Biopharmaceuticals Acquired by Hong Kong’s Gencor Pacific

Jan 13, 2019

Struggling InSight Biopharmaceuticals Acquired by Hong Kong’s Gencor Pacific In 2017, following financial collapse, the intellectual property and assets of Israel-based InSight were sold to Estonian company PharmaEstica Manufacturing and its Israeli partner Meir Orbach 15:3913.01.19 Hong Kong-based pharmaceutical and food retailer Gencor Pacific Ltd. has recently acquired Israel-based pharmaceutical company InSight Biopharmaceuticals Ltd., Gencor’s legal representation for the deal, Tel Aviv-based law firm Pearl Cohen Zedek Latzer Baratz, told Calcalist last week. Gencor paid $2.5 million for the company, according to Pearl Cohen. InSight, founded in the 1990s and based in Israeli city Rehovot, develops complex generic drugs and biosimilars, which are generic, almost identical versions of drugs manufactured from biological sources such as blood or tissue.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

InSight Biopharmaceuticals Patents

InSight Biopharmaceuticals has filed 7 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

1/4/2008

11/1/2011

Drug delivery devices, Dosage forms, Monoclonal antibodies, Immune system, Molecular biology

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

1/4/2008

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

11/1/2011

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Drug delivery devices, Dosage forms, Monoclonal antibodies, Immune system, Molecular biology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.